Point72 (DIFC)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,800
Closed -$4.52M 1564
2025
Q2
$4.52M Sell
5,800
-1,900
-25% -$1.48M 0.17% 143
2025
Q1
$6.36M Buy
7,700
+3,700
+93% +$3.08M 0.26% 104
2024
Q4
$3.09M Buy
4,000
+1,100
+38% +$911K 0.11% 252
2024
Q3
$2.57M Sell
2,900
-19,700
-87% -$17.7M 0.09% 279
2024
Q2
$20.5M Sell
22,600
-12,800
-36% -$10.2M 0.73% 15
2024
Q1
$27.5M Buy
+35,400
New +$25.2M 0.87% 7

Other funds holding LLY

Point72 (DIFC)'s LLY Position: Q3 2025 in Review

Point72 (DIFC) sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 2,653 shares — an estimated $1.97M sold.

Point72 (DIFC) first reported a position in LLY in Q4 2024 and held it in 2 quarters. The position peaked at $4.2M in Q4 2024. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Point72 (DIFC) reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
  • Point72 (DIFC) sold 2,653 Eli Lilly shares in Q3 2025, an estimated $1.97M.
  • Point72 (DIFC) first reported a position in Eli Lilly in Q4 2024 and held it in 2 quarters.
  • Point72 (DIFC)'s Eli Lilly position peaked at $4.2M in Q4 2024.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.